Clinical observations on infliximab treatment of infantile onset Takayasu arteritis

BACKGROUND: There is insufficient evidence on the clinical effectiveness and safety of infliximab (IFX) treatment of Takayasu arteritis (TA) in infants. METHODS: We evaluated the therapeutic effectiveness and safety of IFX in a retrospective case series of 10 infantile TA patients. Observations incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Min, Lai, Jianming, Zhang, Dan, Xu, Yingjie, Zhu, Jia, Li, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351063/
https://www.ncbi.nlm.nih.gov/pubmed/35927694
http://dx.doi.org/10.1186/s12969-022-00708-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351063/
https://www.ncbi.nlm.nih.gov/pubmed/35927694
http://dx.doi.org/10.1186/s12969-022-00708-4

Ejemplares similares